Cite
Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
MLA
Zeying Feng, et al. “Nonselective Beta-Adrenoceptor Blocker Use and Risk of Parkinson’s Disease: From Multiple Real-World Evidence.” BMC Medicine, vol. 21, no. 1, Nov. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12916-023-03122-z.
APA
Zeying Feng, Qiuping Zhao, Jingjing Wu, Yiping Yang, Xinru Jia, Junlong Ma, Haibo Tang, Hong Yuan, Guoping Yang, & Yao Lu. (2023). Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence. BMC Medicine, 21(1), 1–10. https://doi.org/10.1186/s12916-023-03122-z
Chicago
Zeying Feng, Qiuping Zhao, Jingjing Wu, Yiping Yang, Xinru Jia, Junlong Ma, Haibo Tang, Hong Yuan, Guoping Yang, and Yao Lu. 2023. “Nonselective Beta-Adrenoceptor Blocker Use and Risk of Parkinson’s Disease: From Multiple Real-World Evidence.” BMC Medicine 21 (1): 1–10. doi:10.1186/s12916-023-03122-z.